Malasia #6449 (v.2)
Datos básicos
- Notificada en
-
G/MA/QR/N/MYS/2 11/10/2023
- Validez de la versión
-
11/10/2022 -
24/10/2023
Versión anterior v.2
- Miembro informante
- Malasia
- En vigor desde
- Fecha de supresión
- En vigor
- Descripción general
-
Non-automatic licensing on the import of products for the purpose of clinical trials
- Fundamento jurídico nacional
-
Sale of Drugs Act 1952 [Act 368]
Control of Drugs and Cosmetics Regulations 1984 - Mecanismo administrativo
-
Administered by Ministry of Health (MOH).
Details of the requirement on Malaysian Guideline for Application of Clinical Trial Import License and Clinical Trial Exemption can be accessed here:
https://www.npra.gov.my/easyarticles/images/users/1069/CTIL%20Guidelines%20Ed%207%20&%20Form%20Version%2001/Malaysian-Guideline-for-Application-of-CTIL-and-CTX-7th-Edition-28.08.2020.pdf
- Entidades responsables
-
Ministry of Health
- Versión del SA
-
HS 2017
- Signatura de la OMC a que se hace referencia
Metadatos
- Justificaciones en el marco de la OMC
-
XX:(a) - (a) necessary to protect public morals;
GATT 1994 (GATT 1947 provisions)
Notificada como: Articles XX(a) and XX(b) of the GATTXX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Notificada como: Articles XX(a) and XX(b) of the GATT - Compromisos Internacionales (distintos de los asumidos en el marco de la OMC)
-
- Interlocutores afectados
- Interlocutores no afectados
Medidas
- Restricciones notificadas
- NAL
| Signatura |
|---|
|
NAL
|
Líneas arancelarias
|
3001
|
3001
|
Products for the purpose of clinical trials
|
|
|
3002
|
3002
|
Products for the purpose of clinical trials
|
|
|
3003
|
3003
|
Products for the purpose of clinical trials
|
|
|
3004
|
3004
|
Products for the purpose of clinical trials
|
|
|
3005
|
3005
|
Products for the purpose of clinical trials
|
|